SWISF - New to The Street Announces Five Corporate Interviews Episode 535 Airing on the FOX Business Network on Monday December 4 2023 at 10:30 PM PT | Benzinga
NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- New to The Street, an FMW Media business show production, will air episode 535 on the FOX Business Network, Monday, December 4, 2023, at 10:30 PM PT.
New to The Street's episode 535 features the following five (5) corporate interviews:
1). Biopharmaceutical -Acurx Pharmaceuticals, Inc.'s (NASDAQ:ACXP) () interview with David Luci, President/CEO.
2). InsurTech Company - Reliance Global Group, Inc.'s (NASDAQ:RELI) (NASDAQ:RELIW) () interview Ezra Beyman, CEO/Founder.
3). ETF Fund - American Conservative Values ETF's (NYSE:ACVF) () interview with Bill Flaig, CEO/Founder.
4). Pet Health - PetVivo Holdings, Inc.'s (NASDAQ:PETV) (NASDAQ:PETVW) () interview with John Lai, CEO/President.
5). "Sekur Privacy & Sekur Security – Weekly Hack" interview with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX:SWISF) (CSE:SKUR) (FRA: GDT0) (Sekur®).
Episode 535
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Phamaceuticals, Inc. (NASDAQ:ACXP) (). As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections. David updates viewers on the Company's FDA Phase 2 clinical trial on the Ibezapolstat drug, a treatment for patients with Clostridioides difficile Infections (CDI). Based on positive data from Phase 2a and Phase 2b, management is now going forward with the FDA Phase 3. The Company compared its top-line data with the currently used standard-of-care drugs in the marketplace, and Ibezapolstat has impressive positive results. Phases 2a and 2b confirmed that the drug had success in 25 out of 26 patients, approximately 96% success with no reinfections. Competitor drugs have been used for decades to treat CDI, but the reinfection rates are very high. ACXP's Ibezapolstat study results have shown to combat reinfections effectively. Based on the data and other publications regarding the market size for newly discovered and effective treatment of CDI, ACXP believes Ibezapolstat could be a market worth over $1B. David explains how the Company will fund its FDA Phase 3 study and, upon successful approval, will leverage data/results for future approval(s) with the European Medicines Agency. Decades-old antibacterial drugs are not working due to changes in the molecular composition of CDI. Thousands of people worldwide die annually, with many catching CDI in hospitals and nursing homes. Acurx Pharmaceuticals, Inc. believes its Ibezapolstat drug is the next generation for effectively treating CDI. The on-screen QR code is available during the show; download or visit Acurx Pharmaceuticals, Inc. - https://www.acurxpharma.com/.
From the Nasdaq MarketSite Studio, Reliance Global Group, Inc.'s (NASDAQ:RELI) (NASDAQ:RELIW) () CEO/Founder, Ezra Beyman, and New to The Street's TV Host Jane King talk about RELI's insurance business. As an insurance technology-based Company, RELI is transforming the traditional insurance business model. Agency partners become more competitive and productive through the RELI Exchange Partner Network, a proprietary technology platform with advanced automation and artificial intelligence (AI). Starting in 1985, Ezra formed a mortgage company that, in the early 2000s, became the third-largest mortgage company in the US. At the same time, that company held a larger real-estate portfolio, owning properties in several states. In 2005, he started buying insurance agencies, and in 2018, RELI became public on the OTC Markets, later up-listed to the Nasdaq stock exchange, symbol RELI. Ezra tells viewers that he invested around $5M to ensure RELI's operational success. The Company owns approximately eight (8) agencies and is pursuing further acquisitions to scale operations. On November 21, 2023, the Company announced a Letter-of-Intent (LOI) to acquire an agency that Ezra believes could more than double revenues upon successful purchase and integration into the RELI Exchange Network. Customers interested in getting comprehensive insurance quotes can use RELI's 5minuteinsure.com site to get immediate quotes from different providers within five minutes or less. Customers can then evaluate the best coverage and prices and purchase insurance products from the site that fit their needs. RELI Exchange helps agency partners succeed, making the insurance sales process easier and more competitive than large insurance organizations. The competitors' large technology-driven insurance platforms are inefficient and expensive compared to RELI's. Management believes that over the next 12-81 months, they will acquire more agencies, streamline operations, reduce costs, increase profitability, and increase customers and agency partners. The on-screen QR code is available during the show; download or visit Reliance Global Group, Inc.- https://relianceglobalgroup.com/.
American Conservative Values ETF's (NYSE:ACVF) Bill Flaig, Founder/CEO, and New to The Street's Jane King discuss the Fund's conservative investment criteria at the New York Stock Exchange Studio. The Fund looks for investments in conservative-run companies seeking growth for its politically conservative investors. Bill explains that many investors don't realize that their 401(k) and other investment instruments have financial positions in public companies whose management teams are more involved with political ideologies than running a business effectively. Management with political agendas hurt shareholder returns, tarnishing the brands of goods and services produced. Unknowingly, an investor's money might be within investment funds with companies who restrict and promote negativity on conservative attitudes, promoting it on social media platforms, ...